Localisation of mRNA for interleukin-1 receptor and interleukin-1 receptor antagonist in the rat ovary

被引:27
|
作者
Wang, LJ
Brannstrom, M
Cui, KH
Simula, AP
Hart, RP
Maddocks, S
Norman, RJ
机构
[1] UNIV ADELAIDE,QUEEN ELIZABETH HOSP,DEPT OBSTET & GYNAECOL,REPROD MED UNIT,WOODVILLE,SA 5011,AUSTRALIA
[2] RUTGERS STATE UNIV,DEPT BIOL SCI,NEWARK,NJ 07102
[3] UNIV ADELAIDE,WAITE AGR RES INST,DEPT ANIM SCI,ADELAIDE,SA,AUSTRALIA
关键词
D O I
10.1677/joe.0.1520011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interleukin-1 (IL-1) is a multifunctional cytokine with profound effects on ovarian function. The effects of IL-1 on ovarian steroidogenesis have been demonstrated in several species. IL-1 mRNA levels are increased in the thecal layer of the ovulating follicle and IL-1 beta has been shown to induce ovulations in vitro. In this study we have investigated the presence and distribution of the mRNAs for type I IL-1 receptor (IL-1RtI) and for the naturally occurring IL-1 receptor antagonist (IL-1ra) in ovaries of adult cycling rats, to elucidate the target cells for IL-1 action. We have demonstrated the presence of mRNA for both substances by in situ hybridisation and reverse transcription PCR. mRNA for IL-1RtI was not found in primordial follicles but was abundant in the granulosa and thecal layer in developing follicles with stronger signals in the granulosa layer. In the preovulatory and ovulatory follicles, there was a further increase in the signal for IL-1RtI mRNA in the thecal layer compared with the granulosa layer. Corpora lutea were weakly positive at all stages and atretic follicles were largely negative. No mRNA was detected in oocytes of any stage. mRNA for IL-1ra showed a similar distribution to that of IL-1RtI. The changes in distribution suggest an action of IL-1 on rat granulosa cells during follicular development and on thecal cells during ovulation.
引用
收藏
页码:11 / 17
页数:7
相关论文
共 50 条
  • [31] The role of the interleukin-1 receptor antagonist in blocking inflammation mediated by interleukin-1
    Dinarello, CA
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (10): : 732 - 734
  • [33] Expression of interleukin-1α and interleukin-1 receptor antagonist in gingival keratinocytes.
    Yang, QB
    Izumi, Y
    Sueda, T
    JOURNAL OF DENTAL RESEARCH, 1999, 78 (05) : 1122 - 1122
  • [34] Balance of interleukin-1β and interleukin-1 receptor antagonist in human periapical lesions
    Shimauchi, H
    Takayama, S
    Imai-Tanaka, T
    Okada, H
    JOURNAL OF ENDODONTICS, 1998, 24 (02) : 116 - 119
  • [35] Pregnancy induced changes in interleukin-1β and interleukin-1 receptor antagonist in rats
    Fewell, JE
    Fofie, AEA
    FASEB JOURNAL, 2002, 16 (05): : A872 - A872
  • [36] Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease - Discussion
    Mahida, Y
    Cominelli, F
    Jewell, DP
    Elson, CO
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 : 54 - 54
  • [37] Interleukin-1β and interleukin-1 receptor antagonist gene polymorphisms in rheumatoid arthritis
    Huang, CM
    Tsai, FJ
    Wu, JY
    Wu, MC
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2001, 30 (04) : 225 - 228
  • [38] Interleukin-1β and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis
    van der Paardt, M
    Crusius, JBA
    García-González, MA
    Baudoin, P
    Kostense, PJ
    Alizadeh, BZ
    Dijkmans, BAC
    Peña, AS
    van der Horst-Bruinsma, IE
    RHEUMATOLOGY, 2002, 41 (12) : 1419 - 1423
  • [39] Amount of interleukin-1β and interleukin-1 receptor antagonist in periodontitis and healthy patients
    Gilowski, Lukasz
    Wiench, Rafal
    Plocica, Iwona
    Krzeminski, Tadeusz Faustyn
    ARCHIVES OF ORAL BIOLOGY, 2014, 59 (07) : 729 - 734
  • [40] Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome
    Cannon, JG
    Angel, JB
    Abad, LW
    Vannier, E
    Mileno, MD
    Fagioli, L
    Wolff, SM
    Komaroff, AL
    JOURNAL OF CLINICAL IMMUNOLOGY, 1997, 17 (03) : 253 - 261